Ovarian Cancer Risk-Reduction and Screening in <i>BRCA1/2</i> Mutation Carriers-Reference-Cited by-同舟云学术

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers

Published:2024-05-01 Issue:5 Volume:33 Page:624-628
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

DiSilvestro Jessica B.¹^ORCID,Haddad Jessica²,Robison Katina¹,Beffa Lindsey¹,Laprise Jessica¹,Scalia-Wilbur Jennifer¹,Raker Christina¹,Clark Melissa A.²³,Lokich Elizabeth¹,Hofstatter Erin⁴,Dalela Disha⁴,Brown Amy⁵,Bradford Leslie⁶,Toland Maris⁶,Stuckey Ashley¹

Affiliation:

1. Department of Obstetrics-Gynecology, Program in Women’s Oncology, Women and Infants Hospital, Providence, Rhode Island, USA.

2. The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

3. The School of Public Health, Brown University, Providence, Rhode Island, USA.

4. Cancer Genetics and Prevention Program, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.

5. Department of Medical Oncology, Hartford Healthcare Cancer Institute, Hartford, Connecticut, USA.

6. Division of Gynecologic Oncology, Maine Medical Partners, Scarborough, Maine, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/jwh.2023.0621

Reference14 articles.

1. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

2. Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women

3. Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

4. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

5. Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome